ClinicalTrials.Veeva

Menu

Rare Kidney Stone Consortium Patient Registry (RKSC)

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

APRT Deficiency
Dent Disease
Cystinuria
Primary Hyperoxaluria

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00588562
11-001702
1U54DK083908-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT and learn better ways of caring for patients with these diseases.

Full description

This study involves the collection of medical information to create a computer database or registry for patients with PH, Dent disease, cystinuria and APRT deficiency. The information will be entered into the registry by your physician or health care provider. The computer web site for the registry is secure and protected by a required password. Some information which will be entered may include your age at first symptoms of PH,Dent disease, cystinuria or APRT, laboratory values, kidney function and the progress of your health over time. Information for an individual patient can only be viewed by the appropriate physician or staff. Once the information is entered into the registry, you will only be identified by a code number.

Enrollment

730 estimated patients

Sex

All

Ages

Under 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals must have a definitive diagnosis of Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency.
  • Individuals have a family history of a sibling with Primary Hyperoxaluria,Dent Disease, Cystinuria or APRT Deficiency.

Exclusion criteria

  • Individuals who do not have Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency.

Trial design

730 participants in 4 patient groups

Primary Hyperoxaluria patients
Description:
Registry will include data on patients with confirmed diagnosis of Primary Hyperoxaluria.
Dent Disease Patients
Description:
Registry will include data on patients with confirmed diagnosis of Dent Disease.
Cystinuria Patients
Description:
Registry will include data on patients with confirmed diagnosis of Cystinuria.
APRT deficiency Patients
Description:
Registry will include data on patients with confirmed diagnosis of APRT deficiency.

Trial contacts and locations

4

Loading...

Central trial contact

Julie B. Olson, RN; Mayo Clinic Hyperoxaluria Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems